Format

Send to

Choose Destination
Cell Immunol. 2018 Nov;333:65-79. doi: 10.1016/j.cellimm.2018.07.009. Epub 2018 Jul 23.

Immunoglobulin G glycosylation in aging and diseases.

Author information

1
Genos Glycoscience Research Laboratory, Zagreb, Croatia.
2
Genos Glycoscience Research Laboratory, Zagreb, Croatia; University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.
3
Genos Glycoscience Research Laboratory, Zagreb, Croatia. Electronic address: mpezer@genos.hr.

Abstract

The Immunoglobulin G (IgG) glycome is well known for its heterogeneity and shows a significant degree of variation within populations. IgG glycome composition is influenced both by genes and by environment, making it an excellent biomarker of a person's general health state, i.e. biological age. IgG glycosylation appears to be highly regulated, both during homeostasis and in cases of its disturbance. Changes in IgG glycosylation patterns have been observed in aging and in various diseases. Differential IgG glycosylation is known to modulate IgG effector functions and is involved in disease development and progression, representing both a predisposition and a functional mechanism involved in disease pathology. This makes IgG glycosylation analysis a promising add-on to improve existing disease biomarkers.

KEYWORDS:

Aging; Biological age; Biomarker; Differential glycosylation; Disease; IgG glycome

PMID:
30107893
DOI:
10.1016/j.cellimm.2018.07.009
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center